$DJT
Trump Media & Technology Group Corp.

2024 Q4 Form 10-Q Financial Statement

#000114036124045260 Filed on November 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $1.011M $0.00
YoY Change
Cost Of Revenue $123.3K $164.9K
YoY Change 198.55%
Gross Profit $887.6K $3.966M
YoY Change -2249.15%
Gross Profit Margin 87.8%
Selling, General & Admin $17.70M $113.8K
YoY Change 52.81%
% of Gross Profit 1993.8% 2.87%
Research & Development $3.894M $9.716M
YoY Change 76.77%
% of Gross Profit 438.68% 244.96%
Depreciation & Amortization $260.6K $60.40K
YoY Change 1672.79%
% of Gross Profit 29.36% 1.52%
Operating Expenses $21.59M $4.505M
YoY Change 35.46% -36.38%
Operating Profit -$23.65M -$539.1K
YoY Change 48.41%
Interest Expense $246.7K $3.448M
YoY Change -93.15% 37.63%
% of Operating Profit
Other Income/Expense, Net $34.59K
YoY Change
Pretax Income -$19.25M -$1.023M
YoY Change 70.45% -77.64%
Income Tax $0.00 $861.1K
% Of Pretax Income
Net Earnings -$19.25M -$9.178M
YoY Change 57.87% 76.55%
Net Earnings / Revenue -1904.09%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.10 -$0.05
COMMON SHARES
Basic Shares Outstanding 216.9M 194.7M
Diluted Shares Outstanding 200.8M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $672.9M $395.0K
YoY Change 20379.68% 39800.0%
Cash & Equivalents $372.1M $395.0K
Short-Term Investments $300.7M
Other Short-Term Assets $9.234M $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses $0.00
Receivables $14.80K $81.00K
Other Receivables $0.00
Total Short-Term Assets $682.1M $395.0K
YoY Change 20661.18% 133.27%
LONG-TERM ASSETS
Property, Plant & Equipment $4.791M $29.20K
YoY Change
Goodwill $132.2M $0.00
YoY Change
Intangibles $15.81M $0.00
YoY Change
Long-Term Investments $310.6M
YoY Change 3.43%
Other Assets
YoY Change
Total Long-Term Assets $155.6M $310.6M
YoY Change -49.34% 3.43%
TOTAL ASSETS
Total Short-Term Assets $682.1M $395.0K
Total Long-Term Assets $155.6M $310.6M
Total Assets $837.8M $311.0M
YoY Change 169.82% 3.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.496M $1.601M
YoY Change
Accrued Expenses $3.293M $47.10M
YoY Change -92.46% 174.39%
Deferred Revenue $1.960M $4.413M
YoY Change
Short-Term Debt $0.00 $6.783M
YoY Change -100.0% 93.75%
Long-Term Debt Due $4.750M $0.00
YoY Change
Total Short-Term Liabilities $14.36M $56.18M
YoY Change -73.28% 149.98%
LONG-TERM LIABILITIES
Long-Term Debt $4.684M $0.00
YoY Change
Other Long-Term Liabilities $2.175M $10.06M
YoY Change -78.38% 0.0%
Total Long-Term Liabilities $6.859M $10.06M
YoY Change -31.84% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.36M $56.18M
Total Long-Term Liabilities $6.859M $10.06M
Total Liabilities $21.22M $66.24M
YoY Change -66.75% 103.59%
SHAREHOLDERS EQUITY
Retained Earnings -$2.908B -$63.87M
YoY Change 4789.37% 106.11%
Common Stock $3.727B $8.800K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.909M $0.00
YoY Change
Treasury Stock Shares
Shareholders Equity $816.5M -$63.87M
YoY Change
Total Liabilities & Shareholders Equity $837.8M $311.0M
YoY Change 169.82% 3.5%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$19.25M -$9.178M
YoY Change 57.87% 76.55%
Depreciation, Depletion And Amortization $260.6K $60.40K
YoY Change 1672.79%
Cash From Operating Activities -$21.89M -$3.433M
YoY Change 1902.37% 630.56%
INVESTING ACTIVITIES
Capital Expenditures $9.889M $2.200K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$300.7M $0.00
YoY Change -8596.68% -100.0%
Cash From Investing Activities -$310.6M $0.00
YoY Change -8876.07% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 360.7M 542.0K
YoY Change 47481.83% 31.9%
NET CHANGE
Cash From Operating Activities -21.89M -3.433M
Cash From Investing Activities -310.6M 0.000
Cash From Financing Activities 360.7M 542.0K
Net Change In Cash 28.18M -2.891M
YoY Change 779.4% 14452800.0%
FREE CASH FLOW
Cash From Operating Activities -$21.89M -$3.433M
Capital Expenditures $9.889M $2.200K
Free Cash Flow -$31.78M -$3.435M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Other Liability Noncurrent Related Party Type Extensible Enumeration
OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Registrant Name
EntityRegistrantName
Trump Media & Technology Group Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4293042
dei Entity Address Address Line1
EntityAddressAddressLine1
401 N. Cattlemen Rd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Sarasota
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34232
dei City Area Code
CityAreaCode
941
dei Local Phone Number
LocalPhoneNumber
735-7346
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
216924448
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2572700
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9233500
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
327500
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14800
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2981200
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4790600
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29200
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2855100
CY2024Q3 us-gaap Assets
Assets
837754800
CY2023Q4 us-gaap Assets
Assets
3363600
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6657400
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1600700
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
262000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
17282500
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1959700
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4413100
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
734000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65275400
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2175100
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
201600
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1120300
CY2024Q3 us-gaap Liabilities
Liabilities
21221700
CY2023Q4 us-gaap Liabilities
Liabilities
70125500
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
999000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214389622
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214389622
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87500000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87500000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
21500
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8800
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3726957300
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
816533100
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-66761900
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
837754800
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3363600
CY2023Q4 us-gaap Other Liability Noncurrent Related Party Type Extensible Enumeration
OtherLiabilityNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40779
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
372135700
CY2024Q3 us-gaap Assets Current
AssetsCurrent
682126500
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
999000000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010900
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1071300
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2618300
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3379600
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41913900
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7212200
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2189400
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
333600
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4435100
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
978100
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
17697000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1509000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
95910700
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5666700
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
762200
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14700
us-gaap Depreciation And Amortization
DepreciationAndAmortization
771500
us-gaap Depreciation And Amortization
DepreciationAndAmortization
47600
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
24665600
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
4101300
us-gaap Costs And Expenses
CostsAndExpenses
143284100
us-gaap Costs And Expenses
CostsAndExpenses
14028400
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-23654700
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3030000
us-gaap Operating Income Loss
OperatingIncomeLoss
-140665800
us-gaap Operating Income Loss
OperatingIncomeLoss
-10648800
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4653000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
us-gaap Investment Income Interest
InvestmentIncomeInterest
6814500
us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2024Q3 us-gaap Interest Expense
InterestExpense
246700
CY2023Q3 us-gaap Interest Expense
InterestExpense
15071900
us-gaap Interest Expense
InterestExpense
2906500
us-gaap Interest Expense
InterestExpense
37702500
CY2024Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0
CY2023Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-7931200
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-225916000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-660200
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542300
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19248400
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26033100
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-363216100
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49011500
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-19248400
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-26033100
us-gaap Net Income Loss
NetIncomeLoss
-363216100
us-gaap Net Income Loss
NetIncomeLoss
-49011500
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
200833835
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87500000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152943536
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87500000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
200833835
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87500000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152943536
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87500000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
45700
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Share Based Compensation
ShareBasedCompensation
84633700
us-gaap Share Based Compensation
ShareBasedCompensation
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001849635
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Assets
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Assets
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Liabilities
CY2024Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#Liabilities
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
300742500
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15811600
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
353200
CY2024Q3 us-gaap Goodwill
Goodwill
132171000
CY2023Q4 us-gaap Goodwill
Goodwill
0
CY2024Q3 djt Convertible Promissory Notes
ConvertiblePromissoryNotes
0
CY2023Q4 djt Convertible Promissory Notes
ConvertiblePromissoryNotes
41818800
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4749900
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160300
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14363000
CY2024Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
4683600
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
0
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3528200
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
2908700
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
0
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2907537000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66770700
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
123300
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
41300
us-gaap Cost Of Revenue
CostOfRevenue
252900
us-gaap Cost Of Revenue
CostOfRevenue
123800
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3893700
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2202700
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8572500
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-210300
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8782800
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-22768100
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-31550900
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-26033100
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-57584000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-66761900
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-327599700
CY2024Q1 djt Adjustments To Additional Paid In Capital Fair Value Earnout Shares
AdjustmentsToAdditionalPaidInCapitalFairValueEarnoutShares
0
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
300426000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84588000
CY2024Q1 djt Stock Issued During Period Value Reverse Capitalization
StockIssuedDuringPeriodValueReverseCapitalization
219621600
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
210274000
CY2024Q2 djt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
97762300
CY2024Q2 djt Stock Issued During Period Value Issuance Of Earnout Shares
StockIssuedDuringPeriodValueIssuanceOfEarnoutShares
0
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-16368000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
341668300
CY2024Q3 djt Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
20222800
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
344744200
CY2024Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
132009400
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45500
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2908700
CY2024Q3 djt Stock Issued During Period Value Settlement
StockIssuedDuringPeriodValueSettlement
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-19248400
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
816533100
us-gaap Net Income Loss
NetIncomeLoss
-363216100
us-gaap Net Income Loss
NetIncomeLoss
-49011500
us-gaap Paid In Kind Interest
PaidInKindInterest
2780100
us-gaap Paid In Kind Interest
PaidInKindInterest
37702500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
225916000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
660200
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
771500
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48300
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-542300
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Share Based Compensation
ShareBasedCompensation
84633700
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
201200
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3800
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3751400
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1600
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-66100
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-197200
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2453500
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
djt Increase Decrease In Accounts Payable And Operating Lease Liabilities
IncreaseDecreaseInAccountsPayableAndOperatingLeaseLiabilities
1870100
djt Increase Decrease In Accounts Payable And Operating Lease Liabilities
IncreaseDecreaseInAccountsPayableAndOperatingLeaseLiabilities
-66100
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52640000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10467200
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5031200
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2200
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7000000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
300742500
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-312773700
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2200
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
47455000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2500000
djt Proceeds From Merger Related Costs Financing Activities
ProceedsFromMergerRelatedCostsFinancingActivities
233017500
djt Proceeds From Merger Related Costs Financing Activities
ProceedsFromMergerRelatedCostsFinancingActivities
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2908700
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
339463100
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
117949800
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
734976700
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2500000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
369563000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7969400
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2572700
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9808400
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
372135700
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1839000
us-gaap Interest Paid Net
InterestPaidNet
126400
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1897700
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
350426000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
djt Noncash Or Part Noncash Transactions Operating Lease Asset Obtained In Exchange For Operating Lease Obligations
NoncashOrPartNoncashTransactionsOperatingLeaseAssetObtainedInExchangeForOperatingLeaseObligations
2703000
djt Noncash Or Part Noncash Transactions Operating Lease Asset Obtained In Exchange For Operating Lease Obligations
NoncashOrPartNoncashTransactionsOperatingLeaseAssetObtainedInExchangeForOperatingLeaseObligations
0
djt Common Stock Issued For Business Combination
CommonStockIssuedForBusinessCombination
132171000
djt Common Stock Issued For Business Combination
CommonStockIssuedForBusinessCombination
0
djt Common Stock Issued For Underwriter Fees
CommonStockIssuedForUnderwriterFees
10107500
djt Common Stock Issued For Underwriter Fees
CommonStockIssuedForUnderwriterFees
0
CY2024Q1 djt Issuance Of Earnout Shares
IssuanceOfEarnoutShares
40000000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-weight: bold;">Reclassifications</span><span style="font-weight: bold;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"><br/> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">In the third quarter of 2024, we revised the presentation of our statement of operations to reclassify cost of revenue as a component of operating cost and expenses, and resulted in our gross profit no longer being presented within the statement of operations.  We revised the presentation of the statement of operations to reflect changes in the way we manage and evaluate our business due to our launch of content streaming on Truth+. Reclassifications of certain prior period amounts have been made to conform to the current period presentation.</div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Use of Estimates </span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, the fair value of assets acquired and liabilities assumed in business acquisitions, the assessment of recoverability of our goodwill and long-lived assets, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates and assumptions reflected in the unaudited condensed consolidated financial statements relate to and include, but are not limited to, the valuation of convertible promissory notes, derivative liabilities, recoverability of goodwill and intangibles, fair value of short-term investments, useful lives of property and equipment, earn-out shares and stock-based compensation.</div>
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
501700
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
501700
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2453500
djt Deferred Revenue Reorganization Period
DeferredRevenueReorganizationPeriod
P12M
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2024Q3 djt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCash
233017500
CY2024Q3 djt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCash
233017500
CY2024Q3 us-gaap Other Assets
OtherAssets
0
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3292900
CY2024Q3 us-gaap Notes Payable
NotesPayable
10103000
CY2024Q3 djt Reverse Recapitalization Net
ReverseRecapitalizationNet
219621600
djt Bonus Expenses Triggered By Merger
BonusExpensesTriggeredByMerger
6130000
CY2024Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
87500000
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
7854534
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136700583
CY2024Q1 djt Escrow Shares Outstanding
EscrowSharesOutstanding
614640
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
87500000
CY2024Q3 djt Issuance Of Earnout Shares
IssuanceOfEarnoutShares
40000000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
395900
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
126100
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4790600
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29200
CY2024Q3 us-gaap Depreciation
Depreciation
260600
CY2023Q3 us-gaap Depreciation
Depreciation
14700
us-gaap Depreciation
Depreciation
269800
us-gaap Depreciation
Depreciation
48300
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1495900
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1600700
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3920700
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
732600
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2024Q3 djt Franchise Tax Payable Current
FranchiseTaxPayableCurrent
508200
CY2023Q4 djt Franchise Tax Payable Current
FranchiseTaxPayableCurrent
0
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6657400
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1600700
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2855100
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
353200
CY2024Q3 djt Lease Right Of Use Asset
LeaseRightOfUseAsset
2855100
CY2023Q4 djt Lease Right Of Use Asset
LeaseRightOfUseAsset
353200
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
734000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160300
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2175100
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
201600
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2909100
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
361900
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
60900
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
44900
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
152600
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
34400
CY2024Q3 us-gaap Lease Cost
LeaseCost
213500
CY2023Q3 us-gaap Lease Cost
LeaseCost
79300
us-gaap Operating Lease Cost
OperatingLeaseCost
172500
us-gaap Operating Lease Cost
OperatingLeaseCost
134600
us-gaap Short Term Lease Cost
ShortTermLeaseCost
234400
us-gaap Short Term Lease Cost
ShortTermLeaseCost
110100
us-gaap Lease Cost
LeaseCost
406900
us-gaap Lease Cost
LeaseCost
244700
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
250800
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
915300
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
782600
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
771200
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
577100
CY2024Q3 djt Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
87900
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3384900
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
475800
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2909100
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9400000
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
98258000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
40700000
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
240000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
240000
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
98018000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
40460000
CY2024Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2024Q3 djt Debt Instrument Liability Component
DebtInstrumentLiabilityComponent
60783200
CY2023Q4 djt Debt Instrument Liability Component
DebtInstrumentLiabilityComponent
3225200
CY2024Q3 djt Debt Instrument Aggregate Interest Charged
DebtInstrumentAggregateInterestCharged
44781600
CY2023Q4 djt Debt Instrument Aggregate Interest Charged
DebtInstrumentAggregateInterestCharged
42121800
CY2024Q3 djt Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
-542300
CY2023Q4 djt Gain Losses On Extinguishment Of Debt
GainLossesOnExtinguishmentOfDebt
0
CY2024Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
106107100
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
45347000
CY2024Q3 djt Debt Instrument Conversion Of Debt Into Paid In Capital
DebtInstrumentConversionOfDebtIntoPaidInCapital
106107100
CY2023Q4 djt Debt Instrument Conversion Of Debt Into Paid In Capital
DebtInstrumentConversionOfDebtIntoPaidInCapital
0
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
41818800
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3528200
CY2024Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
37234800
CY2024Q3 djt Aggregate Change In Fair Value Of Embedded Derivative
AggregateChangeInFairValueOfEmbeddedDerivative
-207084100
CY2023Q4 djt Aggregate Change In Fair Value Of Embedded Derivative
AggregateChangeInFairValueOfEmbeddedDerivative
18832000
CY2024Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
244318900
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
18402800
CY2024Q3 djt Derivative Liability Conversion Paid In Capital
DerivativeLiabilityConversionPaidInCapital
244318900
CY2023Q4 djt Derivative Liability Conversion Paid In Capital
DerivativeLiabilityConversionPaidInCapital
0
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
17282500
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1120300
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11205934
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
11000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 djt Common Stock Shares Reclassified
CommonStockSharesReclassified
10000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
110000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100000000
CY2024Q1 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
1000000000
CY2024Q1 djt Capital Stock Par Or Stated Value Per Share
CapitalStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
18366228
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.5
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y4M24D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3124999
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.5
djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
10285293
djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue
11.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
11205934
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
11.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P4Y6M21D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
51211118
CY2024Q3 djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriod
11205934
CY2024Q3 djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
11.5
djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms
P4Y6M21D
CY2024Q3 djt Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable
51211118

Files In Submission

Name View Source Status
0001140361-24-045260-index-headers.html Edgar Link pending
0001140361-24-045260-index.html Edgar Link pending
0001140361-24-045260.txt Edgar Link pending
0001140361-24-045260-xbrl.zip Edgar Link pending
djt-20240930.xsd Edgar Link pending
ef20034529_10q.htm Edgar Link pending
ef20034529_ex31-1.htm Edgar Link pending
ef20034529_ex31-2.htm Edgar Link pending
ef20034529_ex32-1.htm Edgar Link pending
ef20034529_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
djt-20240930_cal.xml Edgar Link unprocessable
djt-20240930_def.xml Edgar Link unprocessable
djt-20240930_lab.xml Edgar Link unprocessable
djt-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ef20034529_10q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending